3 Schizophrenia Clinical Trials in Austin, MN (2026)

Q: How do I join a clinical trial in Austin?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you.

Recruiting Schizophrenia Studies in Austin

NCT07145918Recruiting

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

Schizophrenia is a common and severe psychiatric illness characterized by extreme disturbances of cognition and thought, affecting language, perception and sense of self. This study will assess advers...

Austin, MN268 participantsAbbVie

View Study Details

NCT07061288Recruiting

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

A study to evaluate the safety, tolerability, and PK of an injectable form of KarXT in participants with schizophrenia...

Austin, MN116 participantsBristol-Myers Squibb

View Study Details

NCT07615426Recruiting

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

The purpose of this study is to see how feasible it is to enroll participants with schizophrenia and for them to complete the study/assessments. It will also assess how safe and tolerable aticaprant i...

Austin, MN64 participantsJanssen Research & Development, LLC

View Study Details

About Schizophrenia Clinical Trials in Austin

Schizophrenia is a chronic brain disorder affecting approximately 2.8 million US adults, characterized by hallucinations, delusions, disorganized thinking, and cognitive difficulties. While current treatments rely primarily on first- and second-generation antipsychotics (risperidone, olanzapine, clozapine), many patients experience incomplete symptom relief or significant side effects. Clinical trials are testing novel mechanisms including muscarinic receptor agonists (like KarXT/xanomeline-trospium), trace amine-associated receptor 1 (TAAR1) agonists, glutamate modulators, and long-acting injectable formulations. Treatment-resistant schizophrenia remains a major focus area, with trials seeking patients who have not adequately responded to standard antipsychotic therapy.

There are currently 3 schizophrenia clinical trials recruiting participants in Austin, MN. These studies are seeking a combined 448 participants. Research is being sponsored by AbbVie, Bristol-Myers Squibb, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Schizophrenia Clinical Trials in Austin — FAQ

Are there schizophrenia clinical trials in Austin?

Yes, there are 3 schizophrenia clinical trials currently recruiting in Austin, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Austin?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you about next steps.

Are clinical trials in Austin free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Austin studies also compensate for your time and travel.

What schizophrenia treatments are being tested?

The 3 active trials in Austin are testing new therapies including novel drugs, biologics, and treatment approaches for schizophrenia.

Data updated July 13, 2026 from ClinicalTrials.gov